E. Monteverde, a partner at Faruqi
& Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of Auxilium
Pharmaceuticals Inc. ("Auxilium" or the "Company") (NASDAQ:AUXL) for
potential breaches of fiduciary duties in connection with the sale of
the Company to QLT Inc. ("QLT") in an all-stock deal valued at
approximately $851 million. The Company's stockholders will only receive
3.1359 QLT shares for each share of Auxilium common stock they own.
Ultimately, Auxilium shareholders will own 76 percent of the combined
company, while QLT shareholders will own the remaining 24 percent.
Auxilium will be re-incorporating to Canada.
Click here for more information: www.faruqilaw.com/AUXL.
There is no cost or obligation to you.
The investigation focuses on whether Auxilium's Board of Directors
breached their fiduciary duties to the Company's stockholders by failing
to conduct a fair sales process and whether and by how much this
proposed transaction undervalues the Company to the detriment of
& Faruqi, LLP is a national law firm which represents investors
and individuals in class action litigation. The firm is focused on
providing exemplary legal services in complex litigation in the areas of
securities, shareholder, antitrust and consumer litigation, throughout
all phases of litigation. The firm has an experienced trial team which
has achieved significant victories on behalf of the firm's clients. To
keep track of the latest securities litigation news, follow us on
Twitter at www.twitter.com/MergerActivity
or on Facebook at www.facebook.com/FaruqiLaw.
If you own common stock in Auxilium and wish to obtain additional
information and protect your investments free of charge, please visit us
or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2014 Faruqi & Faruqi, LLP. The law firm
responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We are happy to discuss your particular case.
[ Back To NFVZone's Homepage ]